MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuroscience Letters

• Publication date

  2015-10-08

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neulet.2015.08.038PMID 26314506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenetic and therapeutic applications of microRNAs in major depressive disorder.

  2016cited by this paper
• Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression.

  2014cited by this paper
• Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients.

  2014cited by this paper
• miR-1202: A Primate Specific and Brain Enriched miRNA Involved in Major Depression and Antidepressant Treatment

  2014cited by this paper
• Food for thought: understanding the value, variety and usage of management algorithms for major depressive disorder

  2014cited by this paper
• A Real-Time Method for Measuring cAMP Production Modulated by Gαi/o-Coupled Metabotropic Glutamate Receptors

  2014cited by this paper
• Adolescent depression: clinical features and therapeutic strategies.

  2013cited by this paper
• Role of mGluR4 in acquisition of fear learning and memory.

  2013cited by this paper
• Blood microRNA changes in depressed patients during antidepressant treatment.

  2013cited by this paper
• Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression

  2012cited by this paper
• MicroRNA Expression Is Down-Regulated and Reorganized in Prefrontal Cortex of Depressed Suicide Subjects

  2012cited by this paper
• Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

  2012cited by this paper
• Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders

  2012cited by this paper
• MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia.

  2011cited by this paper
• The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

  2011cited by this paper
• NeurimmiRs: microRNAs in the neuroimmune interface.

  2011cited by this paper
• A psychoneuroimmunological review on cytokines involved in antidepressant treatment response

  2010cited by this paper
• MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants

  2010cited by this paper
• The widespread regulation of microRNA biogenesis, function and decay

  2010cited by this paper
• Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons.

  2009cited by this paper
• Detrimental consequences of brain injury on peripheral cells.

  2009cited by this paper
• Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers

  2008cited by this paper
• Biological principles of microRNA-mediated regulation: shared themes amid diversity

  2008cited by this paper
• Mood disorders: regulation by metabotropic glutamate receptors.

  2008cited by this paper
• Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms

  2008cited by this paper
• The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

  2007cited by this paper
• Signaling Pathways Regulating Gene Expression, Neuroplasticity, and Neurotrophic Mechanisms in the Action of Antidepressants: A Critical Overview

  2006cited by this paper
• Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity.

  2001cited by this paper
• Coordinate Regulation of the Cyclic AMP System with Firing Rate and Expression of Tyrosine Hydroxylase in the Rat Locus Coeruleus: Effects of Chronic Stress and Drug Treatments

  1992cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Down-Regulation of Acyloxyacyl Hydrolase Expression in Alzheimer’s Disease Impairs LPS Detoxification and Contributes to Brain Pro-Inflammatory Signaling

  2026cites this paper
• Glucocorticoids regulate small extracellular vesicle (sEV) release via activation of nSMase2

  2025cites this paper
• Fructus Arctii Mitigates Depressive Disorder via the Let‐7e‐Modulated Toll‐Like Receptor (TLR) Signaling Pathway

  2024cites this paper
• miRNAs in Major Depression: Possible Association of miR-17 and miR-92 with Childhood Traumas

  2024cites this paper
• MicroRNA-specific targets for neuronal plasticity, neurotransmitters, neurotrophic factors, and gut microbes in the pathogenesis and therapeutics of depression.

  2024cites this paper
• Deciphering the role of miRNA-134 in the pathophysiology of depression: A comprehensive review

  2024cites this paper
• Elucidation of molecular processes and biomarkers linked to the genetic variations driving the etiology of mood disorders

  2024cites this paper
• Identifying the differentially expressed peripheral blood microRNAs in psychiatric disorders: a systematic review and meta-analysis

  2024cites this paper
• The role of ncRNAs in depression

  2024cites this paper
• Evaluating the Connection between MicroRNAs and Long Non-Coding RNAs for the Establishment of the Major Depressive Disorder Diagnosis

  2024cites this paper
• Psychological stress disturbs bone metabolism via miR-335-3p/Fos signaling in osteoclast

  2024cites this paper
• Clinical Insights into MicroRNAs in Depression: Bridging Molecular Discoveries and Therapeutic Potential

  2024cites this paper
• Low expression of GRM4 is associated with poor prognosis and tumor immune infiltration in glioma

  2024cites this paper
• MiR-1281 is involved in depression disorder and the antidepressant effects of Kai-Xin-San by targeting ADCY1 and DVL1

  2023cites this paper
• MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control

  2023cites this paper
• MicroRNA 335-5p: The Sodium Channel Silencer

  2023cites this paper
• Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential

  2023cites this paper
• Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders

  2023cites this paper
• The VEGF protein levels, miR-101-3p, and miR-122-5p are dysregulated in plasma from adolescents with major depression.

  2023cites this paper
• Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior

  2023cites this paper
• Differential expression of serum extracellular vesicle microRNAs and analysis of target-gene pathways in major depressive disorder

  2022cites this paper
• MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control

  2022cites this paper
• MAD2B Blunts Chronic Unpredictable Stress and Corticosterone Stimulation–Induced Depression-Like Behaviors in Mice

  2022influential citation
• Association of Polymorphic Variants in Argonaute Genes with Depression Risk in a Polish Population

  2022cites this paper
• miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders

  2022cites this paper
• A New Player in Depression: MiRNAs as Modulators of Altered Synaptic Plasticity

  2022cites this paper
• A new perspective on depression and neuroinflammation: Non-coding RNA.

  2022cites this paper
• Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review.

  2022cites this paper
• MicroRNAs, Multiple Sclerosis, and Depression

  2021cites this paper
• The important roles of microRNAs in depression: new research progress and future prospects

  2021cites this paper
• MicroRNA binding site variation is enriched in psychiatric disorders

  2021cites this paper
• Physiology and miRNA expression in confined sows with different pupillary light reflex

  2021cites this paper
• The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder.

  2021cites this paper
• Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers

  2021cites this paper
• The miRNome of Depression

  2021cites this paper
• Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators

  2021cites this paper
• Emerging role of microRNAs as novel targets of antidepressants.

  2021cites this paper
• Targeting metabotropic glutamate receptor 4 for cancer immunotherapy

  2021cites this paper
• Restraint Stress in Mice Alters Set of 25 miRNAs Which Regulate Stress- and Depression-Related mRNAs

  2020cites this paper
• miR-335 over-expression in ventrolateral orbital cortex specifically down-regulates GRM4 to improve depressive behaviors in mice

  2020cites this paper
• The association between depression and gastroesophageal reflux based on phylogenetic analysis of miRNA biomarkers.

  2020cites this paper
• Role of miRNAs in depression vulnerability or resilience: novel targets for preventive strategies?

  2020cites this paper
• Association between the group III metabotropic glutamate receptor gene polymorphisms and attention-deficit/hyperactivity disorder and functional exploration of risk loci.

  2020cites this paper
• MiR-497 promotes microglia activation and proinflammatory cytokines production in chronic unpredictable stress-induced depression via targeting FGF2.

  2020cites this paper
• Exploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders

  2020cites this paper
• Neuronal Development-Related miRNAs as Biomarkers for Alzheimer's disease, Depression, Schizophrenia and Ionizing Radiation Exposure.

  2020cites this paper
• Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders

  2019influential citation
• Role of Non-coding RNA in the Pathogenesis of Depression.

  2019cites this paper
• Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders.

  2019cites this paper
• miRNAs in depression vulnerability and resilience: novel targets for preventive strategies

  2019cites this paper
• MicroRNAs expressed in depression and their associated pathways: A systematic review and a bioinformatics analysis

  2019cites this paper
• The Missing Link: How Exosomes and miRNAs can Help in Bridging Psychiatry and Molecular Biology in the Context of Depression, Bipolar Disorder and Schizophrenia

  2019cites this paper
• Distinguishing and phenotype monitoring of traumatic brain injury and post-concussion syndrome including chronic migraine in serum of Iraq and Afghanistan war veterans

  2019cites this paper
• A pilot study on differential expression of microRNAs in the ventromedial prefrontal cortex and serum of sows in activity restricted crates or activity free pens

  2019cites this paper
• MicroRNAs in Major Depressive Disorder.

  2019cites this paper
• MicroRNAs and exosomes in depression: Potential diagnostic biomarkers

  2018cites this paper
• Using Epigenetic Tools to Investigate Antidepressant Response.

  2018cites this paper
• Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats

  2018cites this paper
• MiR-221 is involved in depression by regulating Wnt2/CREB/BDNF axis in hippocampal neurons

  2018cites this paper
• Dysregulation of miR-499, miR-708 and miR-1908 during a depression episode in bipolar disorders.

  2017cites this paper
• MicroRNA in glutamate receptor-dependent neurological diseases.

  2017cites this paper
• Circulating microRNAs as biomarkers for depression: Many candidates, few finalists.

  2017cites this paper
• Chapter 13 – Small RNA Dysregulation in Neurocognitive and Neuropsychiatric Disorders

  2017cites this paper
• Increased Levels of miR-30e, miR-132, miR-185, and miR- 212 at Baseline and Increased Brain-derived Neurotrophic Factor Protein and mRNA Levels after Treatment in Patients with Major Depressive Disorder

  2017cites this paper
• A polymorphism in DICER 1 gene is associated with major depressive disorder risk

  2017cites this paper
• Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future

  2017influential citation
• Noncoding RNAs in Depression.

  2017cites this paper
• The significance of microRNAs in the course of rDD

  2017cites this paper
• Bipolar Disorder Associated microRNA, miR-1908-5p, Regulates the Expression of Genes Functioning in Neuronal Glutamatergic Synapses

  2016cites this paper
• A miR-335/COX-2/PTEN axis regulates the secretory phenotype of senescent cancer-associated fibroblasts

  2016cites this paper
• MicroRNA 101b Is Downregulated in the Prefrontal Cortex of a Genetic Model of Depression and Targets the Glutamate Transporter SLC1A1 (EAAT3) in Vitro

  2016cites this paper
• PTEN axis regulates the secretory phenotype of senescent cancer ‐ associated fibroblasts

  2016cites this paper
• Full title: MicroRNA 101b is downregulated in the prefrontal cortex of a genetic model of depression and targets the glutamate transporter SLC1A1 (EAAT3) in vitro Running title: MiR-101b & SLC1A1 in a depressed rat model

  2016cites this paper
• Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression.

  2016cites this paper